Aptevo Therapeutics Inc.
13F holders, Q1 2024 (March 31)10holders
$4.69avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Aptevo Therapeutics Inc. in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($6K), BlackRock Inc. ($4K) and Morgan Stanley ($910).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L306
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $12K |
| Exits | 0 | $0 |
Ownership 10 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,324 | $6K |
| BlackRock Inc. | 0.00% | New | 890 | $4K |
| Morgan Stanley | 0.00% | New | 194 | $910 |
| Qube Research & Technologies Ltd | 0.00% | New | 100 | $469 |
| Osaic Holdings, Inc. | 0.00% | New | 45 | $211 |
| JPMorgan Chase & Co. | 0.00% | New | 43 | $202 |
| Wells Fargo & Company | 0.00% | New | 36 | $169 |
| Fifth Third Bancorp | 0.00% | New | 6 | $28 |
| PNC Financial Services Group, Inc. | 0.00% | New | 3 | $14 |
| Truvestments Capital LLC | 0.00% | New | 2 | $9 |
"% of holder's portfolio" is APTEVO THERAPEUTICS INC's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.